New hope for aggressive lung cancer: combo therapy enters human trials
NCT ID NCT06362252
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug called ifinatamab deruxtecan (I-DXd) combined with standard immunotherapy (atezolizumab) and sometimes chemotherapy (carboplatin) for people with extensive-stage small cell lung cancer who have not yet been treated. The goal is to see if the combination is safe and helps control the cancer. About 123 adults will take part. This is an early-phase trial, so the main focus is safety and finding the right dose.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EXTENSIVE-STAGE SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Advent Health Orlando
RECRUITINGOrlando, Florida, 32804, United States
-
Astera Cancer Care
RECRUITINGEast Brunswick, New Jersey, 08816, United States
-
CHU Nantes - Hôpital Guillaume et René Laënnec
RECRUITINGSaint-Herblain, 44805, France
-
Centre Léon Bérard
RECRUITINGLyon, 69008, France
-
Chu Rennes - Hopital Pontchaillou
RECRUITINGRennes, 35000, France
-
Columbia University Hervert Irving Comprehensive Cancer Center
RECRUITINGNew York, New York, 10032, United States
-
Dartmouth-Hitchcock Medical Center
RECRUITINGLebanon, New Hampshire, 03766, United States
-
David Geffen School of Medicine
NOT_YET_RECRUITINGLos Angeles, California, 90095, United States
-
Fujita Health University Hospital
RECRUITINGToyoake-shi, 470-1192, Japan
-
Henry Ford Hospital
ACTIVE_NOT_RECRUITINGDetroit, Michigan, 48202, United States
-
Hoag Memorial Hospital Presbyterian
RECRUITINGNewport Beach, California, 92663, United States
-
Hopital Albert Calmette - Chu Lille
RECRUITINGLille, 59037, France
-
Hopital Tenon
RECRUITINGParis, 75020, France
-
Hospital Alvaro Cunqueiro
RECRUITINGVigo, 36312, Spain
-
Hospital Clinic de Barcelona
RECRUITINGBarcelona, 08036, Spain
-
Hospital General Universitario Gregorio Marañon
RECRUITINGMadrid, 28007, Spain
-
Hospital Regional Universitario de Malaga
RECRUITINGMálaga, 29010, Spain
-
Hospital Universitari Vall D'Hebron
RECRUITINGBarcelona, 8035, Spain
-
Hospital Universitario 12 de Octubre
RECRUITINGMadrid, 28041, Spain
-
Hospital Universitario Ramon Y Cajal
RECRUITINGMadrid, 28034, Spain
-
Hospital Universitario Virgen Del Rocio
RECRUITINGSeville, 41013, Spain
-
Hospital Universitario Virgen Macarena
RECRUITINGSeville, 41009, Spain
-
Hôpital Foch
RECRUITINGSuresnes, 92151, France
-
Hôpital de la Timone
RECRUITINGMarseille, 13005, France
-
ICO l'Hospitalet - Hospital Duran i Reynals
RECRUITINGL'Hospitalet de Llobregat, 08908, Spain
-
Ico Girona - Hospital Universitari de Girona Dr Josep Trueta
RECRUITINGGirona, 17007, Spain
-
Institut Curie - Site de Paris
RECRUITINGParis, 75005, France
-
Institut Gustave Roussy
NOT_YET_RECRUITINGVillejuif, 94805, France
-
John Theurer Cancer Center At Hackensack Umc
RECRUITINGHackensack, New Jersey, 07601, United States
-
Kansai Medical University Hospital
RECRUITINGHirakata-shi, 573-1191, Japan
-
Kindai University Hospital
RECRUITINGŌsaka-sayama, 589-8511, Japan
-
Lancaster General Hospital - Ann B Barshinger Cancer Institute
RECRUITINGLancaster, Pennsylvania, 17601, United States
-
Mayo Clinic
RECRUITINGRochester, Minnesota, 55905, United States
-
Mayo Clinic Arizona
RECRUITINGPhoenix, Arizona, 85054, United States
-
Mayo Clinic-Jacksonville
RECRUITINGJacksonville, Florida, 32224, United States
-
Medical College of Wisconsin
RECRUITINGMilwaukee, Wisconsin, 53226, United States
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10021, United States
-
Moffitt Cancer Center
RECRUITINGTampa, Florida, 33612, United States
-
Montefiore Medical Center
RECRUITINGNew York, New York, 10461, United States
-
NHO Himeji Medical Center
RECRUITINGHimeji-shi, 670-8520, Japan
-
NYU Langone Hospital - Long Island
RECRUITINGMineola, New York, 11501, United States
-
National Cancer Center Hospital East
RECRUITINGKashiwa, 277-8577, Japan
-
New York University Cancer Center - Laura and Isaac Perlmutter Cancer Center At Nyu Langone
RECRUITINGMineola, New York, 11501, United States
-
Next Madrid
RECRUITINGMadrid, 28223, Spain
-
Next Virginia
RECRUITINGFairfax, Virginia, 22031, United States
-
Niigata Cancer Center Hospital
RECRUITINGNiigata, 951-8566, Japan
-
Northwest Cancer Specialists, P.C.-Vancouver
RECRUITINGVancouver, Washington, 98684, United States
-
Okayama University Hospital
RECRUITINGOkayama, 700-8558, Japan
-
Regents of the University of Minnesota
RECRUITINGMinneapolis, Minnesota, 55455, United States
-
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
RECRUITINGChicago, Illinois, 60611, United States
-
Scri Oncology Partners
RECRUITINGNashville, Tennessee, 37203, United States
-
Shizuoka Cancer Center
RECRUITINGNagaizumi-cho, 411-8777, Japan
-
Social Welfare Organization Saiseikai Imperial Gift Foundation, Inc. Saiseikai Kumamoto Hospital
RECRUITINGKumamoto, 861-4193, Japan
-
The Cancer Institute Hospital of Jfcr
RECRUITINGKōtoku, 135-8550, Japan
-
Thomas Jefferson University Hospital - Central
RECRUITINGPhiladelphia, Pennsylvania, 19107, United States
-
Tokushima University Hospital
RECRUITINGTokushima, 770-8503, Japan
-
University of Alabama -Birmingham
RECRUITINGBirmingham, Alabama, 35233, United States
-
University of Pennsylvania, Abramson Cancer Center
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Drug attack shrink tough lung cancers?
- Can a smartphone app ease the burden of advanced lung cancer?
- Cholesterol-Lowering drug may boost lung cancer immunotherapy
- Lung cancer drug tislelizumab under Real-World scrutiny in 440-Patient european study
- New combo shows promise for tough lung cancer
- New hope for tough lung cancer: combo therapy enters phase II trial